Send to a Friend Font Size: Increase Decrease

DSNKY and MRK Related Headlines

Apr 13, 2026 07:00AM Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Bas

DSNKY and MRK Related Press Releases

Apr 13, 2026 07:00AM Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Bas

DSNKY and MRK Related SEC Filings